BKBilal Kovan

Bilal Kovan

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Bilal Kovan has a total of 48 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Open Access

    Y-90 Microsphere Radioembolization Dosimetry

    by Bilal Kovan, Muhammed Medyenoğlu, Mustafa Demir, Semra Özdemir

    Y-90 Microsphere Radioembolization Dosimetry - Nuclear Medicine Seminars

  • Open Access

    Impact of extended [177Lu] Lu-PSMA-617 therapy on absorbed kidney dose and CKD-EPI values: how long can therapy be safely continued?

    by Edanur Topal, Bilal Kovan, Ayca İrIbas, Serkan Kuyumcu, Mert Basaran, Aydan Malçok Demirtaş, Oner Sanli, Yasemin Sanli

    Purpose: This study aimed to evaluate the personalized dosimetric approach by calculating the cumulative renal absorbed dose (cRD) and assessing its impact on renal functions in patients diagnosed with metastatic castration-resistant prostate cancer who underwent four or more cycles of [177Lu] Lu-PSMA − 617 therapy. Methods: The study included 110 patients who received ≥ 4 cycles of [177Lu] Lu-PSMA − 617 therapy. Whole-body static and abdominal SPECT-CT imaging was performed at 4, 24, and 96 h post-administration. Kidney function was assessed using dynamic renal scintigraphy and biochemical tests conducted prior to treatment. Estimated glomerular filtration rate (eGFR) levels were calculated using the CKD-EPI formula before each treatment cycle and at the 6th week post-treatment. Results: Pearson correlation analysis reveal no significant relationship between cRD and CKD-EPI values (p >.05). No significant differences were observed between pre-treatment CKD-EPI levels and those measured after the 4th, 5th, 6th, 7th, and 8th cycles (p >.05). Among patients reaching a cRD of 23 Gy, a statistically significant difference was observed between pre- and post-treatment CKD-EPI values (p <.05). Of the 13 patients exceeding cRD of 28 Gy, five maintained CKD-EPI levels above 90 mL/min/1.73 m2 post-treatment. Conclusion: Despite treatment-related declines in eGFR levels, our findings indicate that a personalized dosimetric approach may enable extended cycles of [177Lu] Lu-PSMA-617 therapy with manageable nephrotoxicity. Considering the significant inter-patient variability, establishing universal absorbed dose-response relationships remains challenging. Prospective multicenter studies are crucial to refining toxicity thresholds and advancing tailored treatment strategies to optimize safety and efficacy.


  • Open Access

    The Impact of Image Reconstruction Parameters on TARE Treatment Dosimetric Calculation

    by Bilal Kovan, Emine Göknur Işık

    Accurate dosimetric calculations are essential to enhance therapeutic efficacy in Yttrium-90 (Y-90) microsphere therapy, which rely significantly on the three-dimensional imaging parameters used. This study aims to evaluate the reconstruction parameters used to generate three-dimensional images from SPECT data obtained for dosimetric calculations, and to determine the optimal reconstruction parameters. This retrospective study evaluated Single Photon Emission Computed Tomography/Computed Tomography (SPECT/CT) images of 30 patients (8 women and 22 men) who underwent Transarterial Radioembolization (TARE) treatment at our clinic between 2018 and 2019 using Technetium 99mTc-labeled macroaggregated albumin (99mTc-MAA). The SPECT images were reconstructed using 20 different iterations and subset values. The perfused areas were identified using 5% and 10% threshold values. At the 5% threshold, the maximum difference from the average was 20.7% at 2 iterations and 2 subsets. For other parameters, the difference from the average was less than 2.8%. At the 10% threshold, the maximum difference from the average was 14.8% at 2 iterations and 2 subsets, with other parameters again showing a difference of less than 2.8%. For effective TARE treatment, it is recommended to set the SPECT image reconstruction parameters to higher than 5 iterations and 5 subsets following the administration of 99mTc-MAA.

  • Influence of Early Versus Delayed Hepatic Artery Perfusion Scan on 90 Y Selective Internal Radiation Therapy Planning

    by Bilal Kovan, Dilara Denizmen, Caner Civan, Serkan Kuyumcu, Emine Goknur Isik, Duygu Has Simsek, Zeynep Gozde Ozkan, Arzu Poyanli, Bayram Demir, Yasemin Sanli

    Purpose: This study evaluated the effect of an increase in the time interval between hepatic intra-arterial injection of 99m Tc-macroaggregated albumin (MAA) and hepatic artery perfusion scintigraphy (HAPS) on the lung shunt fraction (LSF) and perfused volume (PV) calculations in the treatment planning of selective internal radiation therapy (SIRT). Methods: The authors enrolled 51 HAPS sessions from 40 patients diagnosed with primary or metastatic liver malignancy. All patients underwent scan at the first and fourth hour after hepatic arterial injection of 99m Tc-MAA. Based on single-photon emission computed tomography images, LSF values were measured from each patient's first and fourth hour images. PV1 and PV4 were also calculated based on three-dimensional images using 5% and 10% cutoff threshold values and compared with each other. Results: The authors found that the median of LSF4 was statistically significantly higher than LSF1 (3.05 vs. 4.14, p ≤ 0.01). There was no statistically significant difference between PV1 and PV4 on the 10% ( p = 0.72) thresholds. Conclusions: LSF values can be overestimated in case of delayed HAPS, potentially leading to treatment cancellation due to incorrectly high results in patients who could benefit from SIRT. Threshold-based PV values do not significantly change over time; nevertheless, keeping the short interval time would be safer.


  • Open Access

    INVESTIGATION OF CENTERING PROBLEM IN THE CADMIUM ZINC TELLURIDE (CZT) CARDIAC CAMERA

    by Eda Mutlu, Bilal Kovan, Emine Göknur Işik, Serkan Kuyumcu, Bayram Demi̇r

    Introduction: Cadmium Zinc Telluride (CZT) Cardiac Cameras are a special SPECT cameras with solid state cadmium zinc telluride detectors. This diagnostic method applied in the evaluation of coronary artery disease is well designed for myocardial perfusion scintigraphy. Aim: CZT cardiac cameras have limited detector area. In patients who are morbidly obese or whose heart is not in its normal location in the body, the center of the heart and the isocenter of the device do not coincide. It is aim to investigate how these conditions affect the imaging performance of the CZT cardiac camera. Methods: A homogeneous and spherical ball with a diameter of 4 cm was used for the research. To be able to measure away from the center a wooden phantom with 8 cavities and a total length of 32 cm was designed. The center as reference point has been determined by matching the center of the device with the center of the sphere. For the next imaging, the image were taken by placing the spherical ball in the other cavities, respectively, without changing the center. Results: According to the results obtained, farther from the center, deviations from sphericity and differences in dose distribution were observed. Counts decreased by 1.5% in the 2nd position and 16% in the 3rd position relative to the center in the X-axis. A disaster area has been formed and the image area has been exited from the 4th imaging. Conclusion: It is very important to center the patient as much as possible, otherwise the doctor will misdiagnose.

  • The inferior performance of [68Ga]Ga-FAPI-04 PET/CT as a diagnostic and theranostic biomarker in [177Lu]Lu-DOTATATE refractory well-differentiated neuroendocrine tumors

    by Duygu Has Simsek, Yunus Guzel, Dilara Denizmen, Yasemin Sanli, Fikret Buyukkaya, Bilal Kovan, Halil Komek, Emine Goknur Isik, Zeynep Gozde Ozkan, Serkan Kuyumcu

    Purpose We aimed to investigate the potential of [68Ga]Ga-FAPI-04 PET/CT as an alternative diagnostic and theranostic tool in well-differentiated NETs refractory to [177Lu]Lu-DOTATATE therapy. Methods Patients who received at least two cycles of [177Lu]Lu-DOTATATE therapy for metastatic NETs and progressed under treatment were included. All patients had performed [68Ga]Ga-DOTATATE and [68Ga]Ga-FAPI-04 PET/CT within 3 weeks. The number of PET-positive lesions related to NETs and tumor sites was documented. Mann-Whitney U and chi-square tests were used to compare SUVmax levels of tracers and the number of detected metastases. Results Twelve patients (7 male, 5 female) who met the eligibility criteria were included in the study. Ten patients had grade 1–2 NET of various origins, and two had paraganglioma and pheochromocytoma. One hundred ninety-eight of 230 lesions (86%) were SSTR positive with a median SUVmax of 16.6 (2.2–76.5), and 88 of 230 lesions (38.2%) were [68Ga]Ga-FAPI-04 positive with a median SUVmax of 5.1 (2.3–21). Median SUVmax level and detected number of tumors were significantly higher in [68Ga]Ga-DOTATATE PET/CT (p=68Ga]Ga-FAPI-04 PET/CT was completely (n:2) or almost completely (n:3) negative in 5 (42%) patients. Two (17%) patients had flip-flop SSTR/FAPI uptake in tumors. In four patients (33%), tumor uptake or the number of PET-positive lesions was inferior in [68Ga]Ga-FAPI-04 PET/CT. In only one patient (8%), tumor uptakes were higher in [68Ga]Ga-FAPI-04 PET/CT. Low-dose [177Lu]Lu-FAPI-46 dosimetry was performed on the FAPI-dominant patient; absorbed radiation doses per GBq were 1.26 Gy, 0.36 Gy, 0.32 Gy, and 0.2 Gy for kidneys, liver, spleen, and total body, respectively. The mean absorbed dose per GBq was 0.33 Gy for liver mass and 0.41 Gy for metastatic lymph nodes. Conclusion Our preliminary results demonstrated that [68Ga]Ga-FAPI-04 PET/CT mainly failed in well-differentiated NETs refractory to [177Lu]Lu-DOTATATE therapy and had a limited role as an alternative diagnostic or theranostic agent. Further investigations with a larger patient population are required to determine the impact of [68Ga]Ga-FAPI-04 PET/CT on NETs.


  • Influencing factors of lung shunt fraction in transarterial radioembolization treatment

    by Bilal Kovan, Caner Civan, Emine Goknur Isik, Duygu Has Simsek, Zeynep Gozde Ozkan, Fikret Buyukkaya, Yasemin Sanli, Bayram Demir, Serkan Kuyumcu


  • Open Access

    Influencing Factors of Lung Shunt Fraction in Transarterial Radioembolization Treatment

    by Bilal Kovan, Caner Civan, Emine Göknur Işık, Duygu Has Şimşek, Zeynep Gözde Özkan, Fikret Büyükkaya, Yasemin Şanlı, Bayram Demir, Serkan Kuyumcu

    Purpose We aimed to evaluate the influencing factors of lung shunt fraction(LSF) in patients who underwent transarterial radioembolization treatment. Methods We enrolled 105 patients who had either primary or metastatic liver disease. Planar and SPECT/CT images were obtained after intraarterial injection of 99mTc-MAA to measure LSF. Planar-based LSFs(LSFplanar), calculated as the arythmetic mean(LSFAM) and geometric mean(LSFGM), were compared to LSFSPECT/CT. Subgroup analyses were conducted to assess the impact of scattering and spillover effects in patients with target lesions located near lung. Both lungs were segmented into lower, middle and upper sections(RL,RM,RU,LL,LM,LU). For control group, ten patients with normal lung perfusion scintigraphy were included. Results The mean of LSFSPECT/CT was significantly lower than the mean of LSFGM(6.5 ± 4.1 vs 13.9 ± 8.4, p = < 0.001) and the mean of LSFAM(13.5 ± 8.4%, p = < 0.001). LSFplanar methods overestimated LSF compared to LSFSPECT/CT. LSFGM divided by 2.3 can provide more accurate estimated LSF similar to LSFSPECT/CT. In subgroup analyses, we found that mean values of RL/RU, RM/RU, LL/LU and LM/LU were 9.3 ± 7.4, 2.2 ± 1.2; 1.2 ± 0.4, and 1.2 ± 0.2, respectively. In control group, mean values of RL/RU, RM/RU, LL/LU and LM/LU were within a range of 0.9–1.1. Conclusion LSFSPECT/CT with attenuation correction can provide more accurate results compared to LSFplanar before TARE treatment. In patients who had liver lesions located adjacent to lung, the possible miscalculation of LSFSPECT/CT from scattering and spillover effect could be eliminated by exclusion of 3 cm diameter from inferior border of the right lung.